scholarly journals Generalized Anxiety Disorder and Hypoglycemia Symptoms Improved with Diet Modification

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Monique Aucoin ◽  
Sukriti Bhardwaj
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Glycemic Index ◽  
Causal Link ◽  
Anxiety Symptoms ◽  
Mental Illnesses ◽  
Depression Symptoms ◽  
Generalized Anxiety ◽  
Dietary Glycemic Index ◽  
Refined Carbohydrates

Observational evidence suggests that a relationship may exist between high glycemic index diets and the development of anxiety and depression symptoms; however, as no interventional studies assessing this relationship in a psychiatric population have been completed, the possibility of a causal link is unclear. AB is a 15-year-old female who presented with concerns of generalized anxiety disorder and hypoglycemia symptoms. Her diet consisted primarily of refined carbohydrates. The addition of protein, fat, and fiber to her diet resulted in a substantial decrease in anxiety symptoms as well as a decrease in the frequency and severity of hypoglycemia symptoms. A brief return to her previous diet caused a return of her anxiety symptoms, followed by improvement when she restarted the prescribed diet. This case strengthens the hypothesis that dietary glycemic index may play a role in the pathogenesis or progression of mental illnesses such as generalized anxiety disorder and subsequently that dietary modification as a therapeutic intervention in the treatment of mental illness warrants further study.

Quetiapine. A collection of useful information for the clinician

2021 ◽  
Vol 14 (2) ◽  
pp. 182-185
Author(s):  
Marcin Siwek
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Antipsychotic Drug ◽  
Medical Practice ◽  
Anxiety Symptoms ◽  
Use Cases ◽  
Generalized Anxiety ◽  
Recurrent Depression ◽  
Proven Efficacy

Quetiapine is an antipsychotic drug with proven efficacy in the treatment of schizophrenia and bipolar disorder as well as recurrent depression and generalized anxiety disorder. There is also evidence of the efficacy of quetiapine in other disorders dominated by affective and/or anxiety symptoms, for which treatment is not registered in Poland. The paper presents information useful in medical practice and presents descriptions of use cases.

Women With Generalized Anxiety Disorder Show Increased Repetitive Negative Thinking During the Luteal Phase of the Menstrual Cycle

2020 ◽  
Vol 8 (6) ◽  
pp. 1037-1045
Author(s):  
Sophie H. Li ◽  
Thomas F. Denson ◽  
Bronwyn M. Graham
Keyword(s):  
Anxiety Disorder ◽  
Menstrual Cycle ◽  
Negative Affect ◽  
Generalized Anxiety Disorder ◽  
Cognitive Processes ◽  
Luteal Phase ◽  
Anxiety Symptoms ◽  
Generalized Anxiety ◽  
Repetitive Negative Thinking ◽  
Negative Thinking

Repetitive negative thinking (RNT) is a transdiagnostic feature of psychiatric disorders. Women report greater RNT than do men, yet the association between uniquely female characteristics, such as fluctuating sex hormones during the menstrual cycle, and RNT has not been established. Here we examined changes in RNT and anxiety symptoms across the menstrual cycle in women with ( n = 40) and without ( n = 41) generalized anxiety disorder (GAD). Women with GAD reported an increase in RNT and negative affect from the follicular phase to the luteal phase; unexpectedly, this was not associated with changes in anxiety symptoms, estradiol, or progesterone. Nonanxious women reported no changes in RNT or anxiety symptoms over the menstrual cycle, but higher within-participants progesterone was associated with reduced RNT and negative affect. These results indicate that uniquely female biological processes may influence core cognitive processes that underlie anxiety disorders, but further investigations to determine the implications for symptom severity are required.

P01.63 Venlafaxine er action on generalized anxiety disorder (GAD)-specific anxiety symptoms

2000 ◽  
Vol 15 (S2) ◽  
pp. 337s-337s
Author(s):  
P. Meoni ◽  
D. Hackett ◽  
Y. Brault ◽  
E.O. Salinas
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Anxiety Symptoms ◽  
Generalized Anxiety

scholarly journals The Role of Ethnicity in Expression, Prevalence, and Severity of Generalized Anxiety Disorder and their Overlap with Depressive Symptoms: Epidemiological Evidence from a Rapidly Developing Middle Eastern Country

2021 ◽  
Author(s):  
Salma M. Khaled ◽  
Monica Zolezzi
Keyword(s):  
Depressive Symptoms ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Middle Eastern ◽  
Depression Symptoms ◽  
Generalized Anxiety ◽  
Middle Eastern Country ◽  
Eastern Country ◽  
Symptom Profile ◽  
The Impact

Abstract IntroductionQatar is a small but high-income Middle Eastern country with a large influx of migrants each year. However, the impact of changing population structure and urbanization on prevalence of generalized anxiety symptoms remains unexplored to date. Materials & MethodsA total of 2,640 participants interviewed by phone using the Generalized Anxiety Disorder (GAD-7) and the Patient Health Questionnaire (PHQ-2). Bivariate and multinomial logistic regression analyses were conducted to explore the associations of ethnicity (Arab versus Non-Arab) with severity and symptom profile of GAD and overlap with depressive symptoms. ResultsThe point prevalence of mild, moderate, and severe symptoms were 13.4% (95% CI: 11.9 – 15.0), 2.7% (95% CI: 2.0 – 3.5), and 0.9% (95% CI: 0.6– 1.4), respectively. Arab ethnicity was associated with mild GAD (OR=1.78, p=0.009) and moderate-to-severe GAD (OR=2.36, p=0.044). Relative to non-migrants, migrant types were not significantly associated with mild or with moderate-to- severe GAD. Interactions between depressive symptoms and ethnicity were evident and statistically significant for the association with mild GAD versus no GAD (OR=0.34, p=0.003). ConclusionsEthnicity moderated the association of depression symptoms and GAD severity, with potential implications for early screening and community intervention.

scholarly journals Assessment of Anxiety, Depression and Sleep Disorder Among Cardiology Physicians During COVID-19 Pandemic

2020 ◽  
Author(s):  
ozlem arican ozluk ◽  
Berkay Ekici ◽  
mehdi zoghi ◽  
elif ilkay yüce ◽  
caglar ozmen ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Severity Index ◽  
Burnout Syndrome ◽  
Considerable Proportion ◽  
Depression Symptoms ◽  
Generalized Anxiety ◽  
Event Scale ◽  
Insomnia Severity Index ◽  
Insomnia Severity

Abstract Background: In this study, the anxiety levels and sleep qualities of cardiologists who continue to treat cardiac emergency patients in addition to their epidemic duties during the period when the COVID 19 pandemic was the most intense and the unknown was the most in our country. Methods: This cross-sectional study included 347 cardiologists throughout Turkey from April 17 to 20, 2020. The research was conducted by means of a confidential on-line survey. The research used the Turkish versions of the 7-item Generalized Anxiety Disorder Scale, 7-item Insomnia Severity Index and 9 –item Patient Health Questionnaire.Results : Of the total number of respondents, n= 193 (55.6 %) were aged 31 to 40 years and n= 84 ( 24.2%) were women. 79% of the participants were working in tertiary care centers where cardiac patients and covid patients were admitted and treated more. A considerable proportion of participants reported symptoms of anxiety (54.2 %), insomnia (44.1%), and depression (%71.1). Women cardiologist reported more severe degrees of all measurements of anxiety symptoms and depression symptoms than male cardiologists. Mean Generalized Anxiety Disorder scale scores among women vs male : 6.6 ± 3.5 vs 5.0 ± 4.3 ; p = 0.005 ; mean Insomnia Severity Index scores among women vs male doctors: 7.3±4.3 vs 6.9±4.6; P > 0.05; mean Impact of Event Scale–Revised scores among women vs male cardiologists : 8.0 ± 3.9 vs 6.8± 4.7; p = 0.02. Conclusions: In this survey, during this outbreak most of the cardiologists were found to be mentally challenged while continuing their profession. Especially the anxiety and depression symptoms of female doctor are higher than their male counterparts. The anxiety and stress disorder created by this pandemic may have serious consequences in the future, especially for physicians in intensive branches such as cardiology, who have to serve large patient groups in like low and middle-income countries. It should not be ignored that female doctors working in these branches are more sensitive to burnout syndrome.

scholarly journals Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder

2015 ◽  
Vol 27 (9) ◽  
pp. 1533-1539 ◽  
Author(s):  
Susan G. Ball ◽  
Sarah Lipsius ◽  
Rodrigo Escobar
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Anxiety Symptoms ◽  
Anxiety And Depression ◽  
Generalized Anxiety ◽  
Divergent Validity ◽  
Internal Reliability ◽  
Double Blind ◽  
Remission Status ◽  
Convergent And Divergent Validity

ABSTRACTBackground:The Generalized Anxiety Inventory (GAI) has been developed for use in the assessment of anxiety symptoms in older adults (≥ 65 years), but previous validation work has not examined the psychometric qualities of the instrument in relation to treatment. The objective of this study was to examine the performance of the GAI for its internal reliability, convergent and divergent validity, and its sensitivity to treatment.Methods:Elderly patients with generalized anxiety disorder (GAD) participated in a 10-week double-blind study of duloxetine treatment for patients with GAD. Anxiety symptoms were assessed with the Hamilton Anxiety Rating Scale (HAMA), the Hospital Anxiety and Depression Scale (HADS) anxiety and depression subscales, and the GAI. Internal reliability of the GAI was assessed with Cronbach's α. Correlations among the HAMA, HADS, and GAI scores were analyzed to determine convergent and divergent validity. Patients were also compared on remission status using recommended cut-off scores for the GAI.Results:Patients with GAD, who were at least 65 years of age, were randomly assigned to double-blind treatment with either duloxetine (N = 151) or placebo (N = 140) for 10 weeks acute therapy. The mean change on the GAI was significantly greater with duloxetine compared with placebo treatment (−8.36 vs. −4.96, respectively, p ≤ 0.001). The GAI demonstrated good internal consistency, good convergent and divergent validity, but suggested cut-off values for caseness with the GAI did not correspond to remission status as measured by the HAMA.Conclusions:Within an elderly patient population with GAD, the GAI demonstrated sound psychometric qualities and sensitivity to change with treatment.

Sign in / Sign up

Export Citation Format

Share Document